This finding is consistent with the results of a study on Japanese AD patients [121] and with the observations from the PROSPER and REGARDS trials on the elderly population, which both found no correlation between PCSK9 variants and cognitive performance [122]. This evidence concerns the gene PCSK9 and Alzheimer disease.